Embargoed for 9am CET (3am ET) on Monday November 3rdAmgen Ventures-backed AAVantgarde Bio has raised $143 million in series ...

Scientists have found that they may be able to use the retina's blood vessels to help predict a person's heart disease risk ...

Bio (AAVantgarde), a clinical-stage, biotechnology company pioneering therapies for inherited retinal diseases (IRDs), today announced the successful closing of a $141 million (€122 million) Series B ...

Second-generation anti-VEGF agents, like aflibercept 8 mg and faricimab, show improved efficacy and treatment durability in ...

MHRA response is based on the Phase 3 DRAGON interim analysis results Topline final data expected in Q4 2025 SAN DIEGO, Nov.

A large propensity-matched retrospective cohort study showed a small but statistically significant 7% increase in new-onset ...

The retina of the eye contains photoreceptor cells that convert light into neuronal signals, which ultimately allow us to see. The mammalian retina has a very limited ability to regenerate, and damage ...

D-150 delivers a sustained release of anti-vascular endothelial growth factor with one intravitreal injection.

Black patients with inherited retinal diseases who undergo genetic testing are less likely than White patients to receive a conclusive genetic diagnosis, new research shows. At one center, about 39% ...

Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...

A recent study published in the journal Npj Parkinson's Disease investigated whether increased thinning rate in the parafoveal ganglion cell-inner plexiform layer (pfGCIPL) and peripapillary retinal ...